PharmaSGP Holding SE

    PharmaSGP Holding SE

    XXETR:PSG
    - -
    EUR
    - -
    - -
    14.28P/E
    PharmaSGP Holding SE
    XETR:PSG
    (Deutsche Borse Xetra)

    Recent

    price

    - -

    P/E

    ratio

    14.28

    div

    yld

    - -

    ROIC.AI

    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    EUR
    5.21
    5.27
    5.45
    7.15
    8.43
    10.01
    10.58
    Revenue per Share
    1.39
    0.89
    0.89
    1
    1.37
    1.65
    1.71
    Basic EPS, GAAP
    1.43
    1.21
    -5.93
    1.99
    2.15
    1.97
    1.79
    Free Cash Flow per Basic Share
    0.46
    7.9
    - -
    0.45
    0.49
    1.37
    - -
    Dividend per Share
    - -
    -2.22
    -1.33
    -0.78
    0.1
    0.37
    0.79
    Book Value per Share
    7.85
    0.81
    -5
    -3.57
    -2.19
    -2.26
    -1.75
    Tangible Book Value per Share
    12
    12
    12
    12
    12
    12
    12
    Basic Weighted Avg Shares
    63
    63
    65
    86
    101
    119
    122
    Sales/Revenue/Turnover
    39.13
    25.42
    22.83
    20.6
    24.37
    23.26
    23.06
    Operating Margin (%)
    - -
    - -
    4
    9
    9
    9
    9
    Depreciation Expense
    17
    11
    11
    12
    16
    20
    20
    Net Income, GAAP
    24.96
    24.8
    24.75
    24.36
    25.1
    24.98
    25.06
    Effective Tax Rate (%)
    26.7
    16.82
    16.36
    13.93
    16.22
    16.44
    16.14
    Profit Margin (%)
    94
    9
    -60
    29
    38
    31
    37
    Working Capital
    - -
    - -
    - -
    1
    - -
    - -
    - -
    LT Debt
    96
    12
    22
    31
    40
    32
    37
    Total Equity
    - -
    21.33
    18.68
    19.01
    49.38
    52.67
    47.33
    Return on Invested Capital (%)
    - -
    -82.36
    51.92
    44.08
    -645.9
    612.57
    272.43
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    706
    265.88
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    12
    12
    12
    Market Capitalization
    247
    300
    281

    Working Capital

    EUR

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    67
    54
    60
    Cash, Cash Equivalents & STI
    38
    26
    29
    Accounts Receivable, Net
    16
    13
    17
    Inventories
    11
    10
    10
    Total Current Liabilities
    30
    23
    22
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    10.66%
    -19.6%
    Free Cash Flow
    - -
    -147.91%
    -9.19%
    Net Income, GAAP
    - -
    6.46%
    19.14%
    Sales/Revenue/Turnover
    - -
    14.22%
    17.55%
    Total Cash Common Dividend
    - -
    - -
    177.57%

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    24
    26
    26
    25
    101
    2024
    30
    28
    30
    30
    119
    2025
    33
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.24
    - -
    - -
    - -
    1.37
    2024
    0.38
    - -
    - -
    - -
    1.65
    2025
    0.41
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    0.49
    2024
    - -
    - -
    - -
    - -
    1.37
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business